You are currently viewing a new version of our website. To view the old version click .
  • 21 daysTime to First Decision

Most Recent

  • Article
  • Open Access
124 Views
18 Pages

Enhanced Ocular Retention and Anti-Allergic Efficacy of a Novel HA–Ectoine–CMC Eye Drop for Dry Eye Disease Management

  • Jon Andrade del Olmo,
  • Alejandro Melero,
  • Ander Pino,
  • Nagore Martínez de Cestafe,
  • Oihane Gartziandia,
  • Miguel Ucelay López de Heredia,
  • Josune Torrecilla,
  • Laura Gómez,
  • Sandra Benito Cid and
  • José María Alonso
  • + 1 author

Dry eye disease (DED) is a multifactorial ocular surface disorder that significantly affects vision and quality of life. While artificial tears are the standard first-line therapy, their effectiveness is limited by the complex pathophysiology of DED....

  • Review
  • Open Access
391 Views
21 Pages

The growing threat of Antimicrobial Resistance (AMR) demands innovative drug discovery, yet conventional 2D cell cultures fail to accurately mimic in vivo conditions, leading to high failure rates in preclinical studies. This review addresses the cri...

  • Article
  • Open Access
447 Views
14 Pages

Modeling Power Consumption: A Novel Correlation for Stirred Media Mills with Variable Bead Filling Ratios

  • Simay Ozsoysal,
  • Hamidreza Heidari,
  • Gulenay Guner,
  • Donald J. Clancy and
  • Ecevit Bilgili

Evaluating power consumption in stirred media mills over a wide range of process parameters is crucial for analyzing breakage kinetics and milling efficiency. Despite considerable research efforts, existing models predominantly rely on power-law appr...

  • Opinion
  • Open Access
609 Views
5 Pages

Current estimates suggest that Africa contains about 14% of the world’s population and accounts for 20% of the global burden of disease. Yet, it accounts for a mere 3% of clinical trials globally. The time is ripe—even overdue—for d...

  • Article
  • Open Access
1,555 Views
10 Pages

Background: Off-label nebulization of tranexamic acid (TXA) solution is common practice for the treatment of hemoptysis. However, data regarding nebulization protocols, resulting aerodynamic parameters of the generated aerosol, and corresponding biop...

  • Review
  • Open Access
3,190 Views
29 Pages

Developing a new drug costs approximately one to three billion dollars and takes around ten years; however, this process has only a ten percent success rate. To address this issue, new technologies that combine artificial intelligence (AI) and quantu...

  • Article
  • Open Access
453 Views
13 Pages

PMSSO-Hydrogels as a Promising Carrier for B12 Vitamin

  • Daniil Ialama,
  • Polina Orlova,
  • Anna Skuredina,
  • Ivan Meshkov,
  • Aziz Muzafarov and
  • Irina Le-Deygen

The development of novel dosage forms of vitamin B12 is an urgent task for addressing vitamin deficiency in individuals with gastrointestinal diseases or those following stringent dietary limitations. The study illustrates the fundamental possibility...

  • Feature Paper
  • Article
  • Open Access
1,545 Views
20 Pages

Tablet surface defects are typically controlled by visual inspection in the pharmaceutical industry. This is an insufficient response variable for knowledge-based formulation and process development, and it results in rather limited robustness of the...

  • Article
  • Open Access
614 Views
13 Pages

Poor drug entrapment, burst release, and variable drug release profiles are the most critical challenges associated with biodegradable-polymer-based microspheres. In this study, biodegradable-polymer-based microspheres were used to entrap an antiplat...

  • Article
  • Open Access
926 Views
19 Pages

Aims: To describe and analyze trends in the utilization, spending, and average per prescription price of disease-modifying antirheumatic drugs (DMARDs) in the US Medicaid population. Methods: Using the publicly available national outpatient Medicaid...